Roche (United States)
In research, Roche (United States) stands highest in Medicine (#2,717 of 17,978 worldwide), Health Sciences (#3,628 of 20,462 worldwide) and Life Sciences (#2,575 of 14,347 worldwide), over all time.
- World rank, 2022–2025
- #15,928 of 28,054 · #5,509 all time
- Rank in United States
- #2,253 of 4,192
- Research works
- 1.7k ◆ 1% vs 2013–17
- Citations
- 53k 31.2 per fractional work
- Top-10% rate
- 17.6% record average 16.5%
- Open access
- 28% world 28%
What is Roche (United States) known for in research?
The fields where it stands highest, over all time, ranked among every institution above the floor in each field.
| Field | World rank | Where that sits | Top-10% rate | Works |
|---|---|---|---|---|
| MedicineField | #2,717 of 17,978 | 18.5% | 674 | |
| Health SciencesDomain | #3,628 of 20,462 | 18.4% | 710 | |
| Life SciencesDomain | #2,575 of 14,347 | 19.5% | 570 | |
| Biochemistry, Genetics and Molecular BiologyField | #2,189 of 7,814 | 17.7% | 408 | |
| Molecular BiologySubfield | #2,210 of 4,961 | 16.7% | 267 | |
| Physical SciencesDomain | #10,242 of 21,541 | 14.0% | 324 | |
| ChemistryField | #2,945 of 3,369 | 12.3% | 161 |
Each strip is that field’s whole ranked pool, with the notch where Roche (United States) sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no world mark, because the world rate differs by field (from about 6% to 21% in this record).
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Biochemistry, Genetics and Molecular Biology, 3.5×. Every wedge is a field page.
- Biochemistry, Genetics and Molecular Biology 3.5×
- Veterinary 3.0×
- Immunology and Microbiology 2.6×
- Medicine 2.5×
- Mathematics 1.8×
- Pharmacology, Toxicology and Pharmaceutics 1.2×
- Health Professions 1.1×
- Neuroscience 0.9×
- Computer Science 0.8×
- Psychology 0.7×
- Chemistry 0.6×
- Economics, Econometrics and Finance 0.5×
- Arts and Humanities 0.5×
- Decision Sciences 0.4×
- Physics and Astronomy 0.3×
- Nursing 0.3×
- Environmental Science 0.3×
- Earth and Planetary Sciences 0.3×
- Social Sciences 0.3×
- Agricultural and Biological Sciences 0.3×
- Materials Science 0.2×
- Engineering 0.1×
- Business, Management and Accounting 0.1×
- Dentistry 0.1×
Who are the top researchers at Roche (United States)?
Ranked on the composite score, David C. Swinney, F. H. Schmidt and Julian Symons lead among researchers whose main affiliation is Roche (United States).
- 1 David C. Swinney United States · #216,226 worldwide 304 citations · 17 works
- 2 F. H. Schmidt United States · #428,686 worldwide 99 citations · 15 works
- 3 Julian Symons United States · #432,742 worldwide 42 citations · 25 works
- 4 J. Vollmar United States · #440,141 worldwide 31 citations · 22 works
- 5 H. Spingler United States · #835,822 worldwide 57 citations · 16 works
- 6 G. Klein United States · #947,212 worldwide 35 citations · 16 works
- 7 P. Scigalla United States · #964,646 worldwide 26 citations · 26 works
- 8 E. Rabald United States · #978,302 worldwide 14 citations · 22 works
- 9 Philip Bowring United States · #1,076,820 worldwide 1 citations · 15 works
- 10 K Dietmann United States · #1,126,253 worldwide 22 citations · 15 works
Which keywords describe research at Roche (United States)?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Targeted Therapy, Machine Learning, Precision Medicine, Chemotherapy, Feature Extraction, Medical Imaging, Cell-Free DNA and Texture Analysis.
- Recombinant Proteins
- CT Screening
- Neuroimaging
- Fc Receptors
- Adjuvant Therapy
- Lung Cancer
- Radiotherapy
- Computer-Aided Detection
- SARS-CoV-2
- Convolutional Neural Networks
- Glycosylation
- Therapeutic Antibodies
- Quantitative Analysis
- Cancer Genomics
- Texture Analysis
- Monoclonal Antibodies
- Medical Imaging
- Deep Learning
- Precision Medicine
- Epidemiology
- Machine Learning
- Targeted Therapy
- Chemotherapy
- Feature Extraction
- Cell-Free DNA
- Predictive Modeling
- Clinical Trials
- Mutational Signatures
- Radiomics
- Tumor Heterogeneity
- Biomarkers
- Medical Image Analysis
- Biopharmaceuticals
- Histopathology Images
- Immunogenicity
- Survival Analysis
- Antibody Engineering
- Data Integration
- Tumor Staging
- Positron Emission Tomography
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Machine Learning9▲ 2.9×13 topics
- Epidemiology6▲ 1.61×39 topics
- Targeted Therapy6▲ 28×4 topics
- Precision Medicine6▲ 12×5 topics
- Chemotherapy5▲ 7.5×14 topics
- Deep Learning5▲ 1.49×10 topics
- Feature Extraction5▲ 11×3 topics
- Medical Imaging5▲ 9.6×6 topics
- Cell-Free DNA4▲ 46×2 topics
- Monoclonal Antibodies4▲ 48×3 topics
- Predictive Modeling4▲ 16×2 topics
- Texture Analysis4▲ 19×3 topics
- Clinical Trials4▲ 6.2×9 topics
- Cancer Genomics4▲ 55×1 topic
- Mutational Signatures4▲ 55×1 topic
- Quantitative Analysis4▲ 20×2 topics
- Radiomics4▲ 32×1 topic
- Therapeutic Antibodies4▲ 54×2 topics
- Tumor Heterogeneity4▲ 32×1 topic
- Glycosylation4▲ 32×3 topics
- Biomarkers3▲ 5.2×8 topics
- Convolutional Neural Networks3▲ 4.7×3 topics
- Medical Image Analysis3▲ 18×3 topics
- SARS-CoV-23▲ 8.9×3 topics
- Biopharmaceuticals2▲ 46×3 topics
- Computer-Aided Detection2▲ 27×1 topic
- Histopathology Images2▲ 27×1 topic
- Radiotherapy2▲ 6.1×4 topics
- Immunogenicity2▲ 53×2 topics
- Lung Cancer2▲ 13×2 topics
- Survival Analysis2▲ 8.2×6 topics
- Adjuvant Therapy2▲ 16×2 topics
- Antibody Engineering2▲ 38×1 topic
- Fc Receptors2▲ 38×1 topic
- Data Integration2▲ 12×4 topics
- Neuroimaging2▲ 7.4×3 topics
- Tumor Staging2▲ 18×2 topics
- CT Screening2▲ 27×1 topic
- Positron Emission Tomography2▲ 27×1 topic
- Recombinant Proteins2▲ 59×2 topics
Which research topics does Roche (United States) publish most on?
By volume in 2022–2025: Cancer Genomics and Diagnostics, Radiomics and Machine Learning in Medical Imaging, AI in cancer detection and Monoclonal and Polyclonal Antibodies Research.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Cancer Genomics and Diagnostics Cancer Research 4 works
- 2 Radiomics and Machine Learning in Medical Imaging Radiology, Nuclear Medicine and Imaging 4 works
- 3 AI in cancer detection Artificial Intelligence 2 works
- 4 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 2 works
- 5 Lung Cancer Diagnosis and Treatment Pulmonary and Respiratory Medicine 2 works
- 6 Protein purification and stability Molecular Biology 2 works
- 7 Lung Cancer Treatments and Mutations Pulmonary and Respiratory Medicine 2 works
- 8 SARS-CoV-2 detection and testing Infectious Diseases 2 works
- 9 Biomedical Text Mining and Ontologies Molecular Biology 1 works
- 10 Genomics and Rare Diseases Genetics 1 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Roche (United States)'s research output changed?
Output in 2018–2022 was 1% lower than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in San Francisco
- University of California, San Francisco
- San Francisco State University
- University of San Francisco
- San Francisco VA Medical Center
- University of California San Francisco Medical Center
- San Francisco General Hospital
- Institute on Aging
- California Pacific Medical Center
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.